The Spread of RS-virus Infection and other ARVI not Influenza Etiology in Children and Adults in the Regions of Russia from 2014 to 2016
https://doi.org/10.31631/2073-3046-2018-17-2-16-26
Abstract
Relevance. Respiratory syncytial virus (RSV) is the leading viral cause of acute lower respiratory tract infections in infants and young children in whom this virus is the cause of the primary infection. Goal. The aim of the study is to study the spread of diseases with MS infection in federal districts of Russia
Materials and methods. The Federal Influenza Center collects and automates the processing of weekly information from 24 cities on the number of influenza and acute respiratory viral infections in the total and diagnosed cases (according to polymerase chain reaction) of influenza, RS virus and other acute respiratory viral infections in children (0-2, 6, 7-14 years) and adults (15 years and older).
Results. The average annual incidence of influenza and ARVI, RS virus and Rhino-viral infections, Paragripp and Adenovirus, Boca, Meta and coronas-viral infections in total and in age groups is shown. The structure of the total incidence of influenza and ARVI in the population is presented. An increase in the proportion of acute respiratory viral infections not influenza etiology with a decrease in age, especially, in children 0–2 years old (up to 16.2%) is shown.
Conclusions. Differences in the total incidence of influenza and ARVI and RS infections by age groups, in districts and cities, and in different years have been revealed The earlier onset of incidence of RS infection and the onset of the peak in Khabarovsk and Chita are revealed earlier than in Yekaterinburg and St. Petersburg in all 3 observation seasons.
About the Authors
L. S. KarpovaRussian Federation
E. A. Smorodintseva
Russian Federation
T. J. Sysoeva
Russian Federation
T. P. Stolyarova
Russian Federation
N. M. Popovtseva
Russian Federation
K. A. Stolyarov
Russian Federation
D. M. Danilenko
Russian Federation
L. M. Tsybalova
Russian Federation
References
1. WHO Informal Consultation on Surveillance of RSV on the Global Influenza Surveillance and Response System (GISRS) Platform, 25–27 March 2015. Available at: http://www.who.int/infl uenza/resources/publications/report_rsv_meeting/en/
2. WHO expert working group meeting on RSV surveillance based on the GISRS Platform 2–3 February, 2016. Geneva, Switzerland. Доступно на: http://apps.who.int/iris/bitstream/10665/252625/1/WHO-OHE-PED-GIP-2016.7-eng.pdf
3. WHO technical meeting on piloting RSV surveillance based on the global influenza surveillance and response system. June 2016, Geneva, Switzerland. Available at: http://apps.who.int/iris/bitstream/10665/252617/1/WHO-OHE-PED-GIP-2016.6-eng.pdf
4. WHO strategy to pilot global respiratory syncytial virus surveillance based on the global infl uenza surveillance and response system (GISRS). Geneva, Switzerland, 2017. Available at: http://www.who.int/infl uenza/rsv/.
5. Wright M., Piedimonte G. Respiratory syncytial virus prevention and therapy: past, present, and future. Pediatr. Pulmonol. 2011; 46 (4): 324–347.
6. Nair H., Nokes D. J., Gessner B. D., Dherani M., Madhi S. A., Singleton R. J. et al. Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis. Lancet. 2010; 375 (9725): 1545–1555.
7. Tregoning J. S., Schwarze J. Respiratory viral infections in infants: causes, clinical symptoms, virology, and immunology. Clin. Microbiol. Rev. 2010; 23 (1): 74–98.
8. Walsh E. E. Respiratory syncytial virus infection in adults. Semin. Respir. Crit. Care. Med. 2011; 32 (4): 423–432.
9. Welliver R. C., Checchia P. A., Bauman J. H., Fernandes A. W., Mahadevia P. J., Hall C. B. .Fatality rates in published reports of RSV hospitalizations among high- risk and otherwise healthy children. Curr. Med. Res. Opin. 2010; 26 (9): 2175–2181.
10. Krivitskaya V. Z. Respiratory syncytial virus infection. Pathogenesis, strategy 11. of prevention and treatment. Voprosi sovremennoi pideadrii. [Issues of Modern Pediatrics]. 12. 2013; 12 (2):35–43 (in Russian)..
11. 11. Hon K. L., Leung T. F., Cheng W. Y., Ko N. M., Tang W. K., Wong W. W. et al. Respiratory syncytial virus morbidity, premorbid factors, seasonality, and implications for prophylaxis. J. Crit. Care. 2012; 27 (5): 464–468.
12. 12. Haynes A. K., Prill M. M., Iwane M. K., Gerber S. I. Respiratory Syncytial Virus – United States, July 2012–June 2014. MMWR, December 5 2014; 63 (48): 1133–1136.
13. 13. Tsybalova L. M., Smorodintseva E. A., Karpova L. S., Stolyarov K. A., Sysoeva T. I., Kiselev O. I. The value of RS-virus infection in the epidemiology and etiology of viral respiratory infections in younger children Lechaschii Vrach. [Medical Journal]. 2015; 4: 2–7 (in Russian).
Review
For citations:
Karpova L.S., Smorodintseva E.A., Sysoeva T.J., Stolyarova T.P., Popovtseva N.M., Stolyarov K.A., Danilenko D.M., Tsybalova L.M. The Spread of RS-virus Infection and other ARVI not Influenza Etiology in Children and Adults in the Regions of Russia from 2014 to 2016. Epidemiology and Vaccinal Prevention. 2018;17(2):16-26. (In Russ.) https://doi.org/10.31631/2073-3046-2018-17-2-16-26